"Columbus Memory Center (CMC), located in Columbus, GA, specializes in helping seniors achieve and practice better brain health, memory preservation, dementia prevention, Alzheimer's care and preserving independence. We share realistic hopes, eliminate defeatism and offer free Memory Number® screening for area seniors. CMC offers in-depth screening through the Columbus Memory Project™ and participates in FDA approved clinical research trials aimed at modifying and ultimately eradicating Alzheimer’s disease. CMC is a specialized neurology practice that only accepts patients with a diagnosis of Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Memory Loss."

During the past decade, Columbus Memory Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbus Memory Center" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Eisai Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Cassava Sciences, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbus Memory Center" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Columbus Memory Center" are "Alzheimer Disease" (6 trials), "Early Alzheimer's Disease" (2 trials), "Preclinical Alzheimer's Disease" (2 trials), "Alzheimer Disease (AD)" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Columbus Memory Center" in a lesser frequency.

Most popular intervention types in "Columbus Memory Center" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Donanemab" (2 trials), "Lecanemab" (2 trials), "Aducanumab" (1 trials) and "Bryostatin 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbus Memory Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Columbus Memory Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Columbus Memory Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Columbus Memory Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".